Artelo Biosciences, Inc. (ARTL)
NASDAQ: ARTL · Real-Time Price · USD
1.160
-0.045 (-3.73%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Artelo Biosciences Market Cap
Artelo Biosciences has a market cap or net worth of $3.74 million as of October 24, 2024. Its market cap has decreased by -25.12% in one year.
Market Cap
3.74M
Enterprise Value
-1.59M
1-Year Change
-25.12%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since June 21, 2019, Artelo Biosciences's market cap has decreased from $12.30M to $3.74M, a decrease of -69.56%. That is a compound annual growth rate of -19.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 3.90M | -13.33% |
| Dec 29, 2023 | 4.50M | -45.78% |
| Dec 30, 2022 | 8.30M | -62.27% |
| Dec 31, 2021 | 22.00M | 100.00% |
| Dec 31, 2020 | 11.00M | 18.28% |
| Dec 31, 2019 | 9.30M | -24.39% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biodexa Pharmaceuticals | 4.11M |
| NuCana | 4.10M |
| Sonnet BioTherapeutics Holdings | 3.99M |
| TNF Pharmaceuticals | 3.96M |
| Titan Pharmaceuticals | 3.93M |
| Chromocell Therapeutics | 3.88M |
| Alaunos Therapeutics | 3.83M |
| Hepion Pharmaceuticals | 3.79M |